In previous studies we have shown that, after stimulation by a recepto
r ligand such as thrombin, tissue-type plasminogen activator (tPA) and
von Willebrand factor (vWf) will be acutely released from human umbil
ical vein endothelial cells (HUVEC). However, the mechanisms involved
in the secretion of these two proteins differ in some respects, sugges
ting that the two proteins may be stored in different secretory granul
es. By density gradient centrifugation of rat lung homogenates, a part
icle was identified that contained nearly all tPA activity and antigen
. This particle had an average density of 1.11-1.12 g/ml, both in Nyco
denz density gradients and in sucrose density gradients. A similar den
sity distribution of tPA was found for a rat endothelial cell line and
for HUVEC. After thrombin stimulation of HUVEC to induce tPA secretio
n, the amount of tPA present in high-density fractions decreased, conc
omitant with the release of tPA into the culture medium and a shift in
the density distribution of P-selectin. vWf, known to be stored in We
ibel-Palade bodies, showed an identical distribution to tPA in Nycoden
z gradients. In contrast, the distribution in sucrose gradients of vWf
from both rat and human lung was very different from that of tPA, sug
gesting that tPA and vWf were not present in the same particle. Using
double-immunofluorescence staining of HUVEC, tPA- and vWf-containing p
articles showed a different distribution by confocal microscopy. The d
istribution of tPA also differed from the distribution of tissue facto
r pathway inhibitor, endothelin-1, and caveolin. By immunoelectronmicr
oscopy, immunoreactive tPA could be demonstrated in small vesicles mor
phologically different from the larger Weibel-Palade bodies. It is con
cluded that tPA in endothelial cells is stored in a not-previously-des
cribed, small and dense (d = 1.11-1.12 g/ml) vesicle, which is differe
nt from a Weibel-Palade body.